PSEN1 and Alzheimer disease: Recently, pinocembrin was found to alleviate cognitive deficits in intracerebroventricular Aβ-injected and Aβ-precursor protein (APP)/presenilin 1 (PS1) double transgenic AD mouse models [31, 32].